New Breakthrough: Intranasal Nano-Ivermectin Reduces Brain Tumors by 70% in Preclinical Study
A groundbreaking preclinical study found that intranasal nano-encapsulated ivermectin safely shrank glioblastoma tumors by up to 70% in animal models.
A groundbreaking preclinical study found that intranasal nano-encapsulated ivermectin safely shrank glioblastoma tumors by up to 70% in animal models.
Israeli scientists are hot on the trail of a new way to harness the power of proteins found in the lung. Here’s what we’ve learned so far.
We typically associate viruses as being the body’s enemy, but that’s not always the case. Some are proving to be real winners in the fight against cancer.